Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,236	4,449	4,751	2,426	986	1,352
Market Cap Growth	45.60%	-6.37%	95.88%	146.02%	-27.09%	190.40%
Enterprise Value	3,339	3,463	3,442	1,915	653.55	1,022
Last Close Price	40.46	46.55	51.13	35.58	18.30	28.41
PE Ratio	-	-9.40	-13.86	-9.64	-5.81	-10.15
PS Ratio	561.08	578.08	4572.96	604.45	208.14	1254.39
PB Ratio	4.02	4.48	3.59	4.50	3.12	4.07
P/TBV Ratio	3.84	4.41	3.12	3.83	3.01	3.29
P/FCF Ratio	-	-11.60	-20.30	-14.00	-8.44	-15.19
P/OCF Ratio	-	-11.77	-20.64	-14.39	-8.56	-15.26
EV/Sales Ratio	433.82	449.98	3312.62	477.12	137.97	947.68
EV/EBITDA Ratio	-	-6.75	-10.24	-8.64	-3.92	-9.57
EV/EBIT Ratio	-	-6.70	-10.16	-8.60	-3.89	-9.49
EV/FCF Ratio	-	-9.03	-14.71	-11.05	-5.59	-11.48
Debt / Equity Ratio	0.04	0.04	0.03	0.09	0.01	0.01
Debt / EBITDA Ratio	-0.09	-0.09	-0.15	-0.23	-0.02	-0.03
Debt / FCF Ratio	-0.13	-0.13	-0.22	-0.30	-0.03	-0.04
Net Debt / Equity Ratio	-0.99	-0.99	-0.98	-0.94	-1.05	-1.00
Net Debt / EBITDA Ratio	1.91	1.91	3.88	2.29	1.99	3.10
Net Debt / FCF Ratio	2.55	2.55	5.57	2.93	2.84	3.71
Asset Turnover	0.01	0.01	0.00	0.01	0.01	0.00
Inventory Turnover	1.06	1.06	-	-	-	-
Quick Ratio	12.09	12.09	22.69	12.71	12.06	20.86
Current Ratio	12.32	12.32	23.04	13.07	12.45	21.55
Return on Equity (ROE)	-40.17%	-40.17%	-32.02%	-50.16%	-50.57%	-42.98%
Return on Assets (ROA)	-40.37%	-40.37%	-32.74%	-45.08%	-47.75%	-40.30%
Return on Invested Capital (ROIC)	-2019.92%	-2019.92%	-978.61%	-1373.95%	7581.03%	-4172.07%
Return on Capital Employed (ROCE)	-42.78%	-42.78%	-34.47%	-48.61%	-50.91%	-42.40%
Earnings Yield	-10.78%	-10.63%	-7.22%	-10.37%	-17.21%	-9.86%
FCF Yield	-8.89%	-8.62%	-4.93%	-7.14%	-11.85%	-6.58%
Buyback Yield / Dilution	-16.43%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%
Total Shareholder Return	-16.43%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q